🇺🇸 FDA
Patent

US 8808698

Methods for inhibition of lymphangiogenesis and tumor metastasis

granted A61KA61K2039/505

Quick answer

US patent 8808698 (Methods for inhibition of lymphangiogenesis and tumor metastasis) held by The Regents of the University of California expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K2039/505